Glenmark Pharmaceuticals informs about press release

10 Apr 2017 Evaluate

Glenmark Pharmaceuticals has informed about press release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1009.85 -0.75 (-0.07%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.